thymidine

Also found in: Medical, Encyclopedia, Wikipedia.

thy·mi·dine

 (thī′mĭ-dēn′)
n.
A nucleoside, C10H14N2O5, composed of thymine and deoxyribose.

American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

thymidine

(ˈθaɪmɪˌdiːn)
n
(Biochemistry) the crystalline nucleoside of thymine, found in DNA. Formula: C10H14N2O5
[C20: from thym(ine) + -ide + -ine2]
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014

thy•mi•dine

(ˈθaɪ mɪˌdin)

n.
a nucleoside, C10H14N2O5, containing thymine and deoxyribose, that is a constituent of DNA.
[1910–15; thym(ine) + -idine]
Random House Kernerman Webster's College Dictionary, © 2010 K Dictionaries Ltd. Copyright 2005, 1997, 1991 by Random House, Inc. All rights reserved.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.thymidine - a nucleoside component of DNA; composed of thymine and deoxyribose
nucleoside - a glycoside formed by partial hydrolysis of a nucleic acid
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
Mentioned in
References in periodicals archive
Presently, MT1621 is in late-stage development for the treatment of Thymidine Kinase 2 deficiency.
Modis's lead product candidate, MT1621, an investigational deoxynucleoside substrate enhancement therapy, is in late-stage development for the treatment of Thymidine Kinase 2 deficiency (TK2d), an inherited mitochondrial DNA depletion disorder that predominantly affects children and is often fatal.
Modis's lead product candidate, MT1621, an investigational deoxynucleoside substrate enhancement therapy, is in late-stage development for the treatment of Thymidine Kinase 2 deficiency, an inherited mitochondrial DNA depletion disorder that predominantly affects children and is often fatal.
According to the company, LONSURF consists of a thymidine-based nucleoside analog, trifluridine, and the thymidine phosphorylase (TP) inhibitor, tipiracil, which increases trifluridine exposure by inhibiting its metabolism by TP.
(School of Pharmacy): "Evaluation of transdermal delivery of thymidine phosphorylase inhibitors on inhibition of thrombosis"
Thymidine kinase activity was radioimmunologically measured using the Prolifigen ([R]) thymidine kinase (TK)-radioenzymatic assay (REA) commercial kit (Sangtec Medical, Sweden).
It is a radio-labeled analogue of thymidine, a natural component of DNA.
Copyright © 2003-2025 Farlex, Inc Disclaimer
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.